Treatment options in recurrent ovarian cancer: latest evidence and clinical potential
Ovarian cancer (OC) is the fifth most common cause of cancer death in women. Although significant progress has been made in the treatment of OC, the majority of patients experience disease recurrence and receive second-line and sometimes several lines of treatment. Here we review the options availab...
Main Authors: | Daniela Luvero, Andrea Milani, Jonathan A. Ledermann |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-09-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834014544121 |
Similar Items
-
The latest first-line treatment options for ovarian cancer: focus on maintenance therapy
by: A. A. Rumyantsev
Published: (2020-12-01) -
Advances in thyroid cancer treatment: latest evidence and clinical potential
by: T. Alonso-Gordoa, et al.
Published: (2015-01-01) -
Emerging treatment options for recurrent ovarian cancer: the potential role of olaparib
by: Shaw HM, et al.
Published: (2013-09-01) -
First-line treatment of ovarian cancer: questions and controversies to address
by: Jonathan A. Ledermann
Published: (2018-04-01) -
Nivolumab in melanoma: latest evidence and clinical potential
by: Douglas B. Johnson, et al.
Published: (2015-03-01)